Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-01-05 @ 12:45 PM
Study NCT ID:
NCT00859469
Status:
COMPLETED
Last Update Posted:
2019-10-30
First Post:
2009-03-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
Sponsor:
Columbia University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AAAA2861
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None